These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2145125)
1. The significance of tixocortol-pivalate-positive patch tests in leg ulcer patients. Wilkinson M; Cartwright P; English JS Contact Dermatitis; 1990 Aug; 23(2):120-1. PubMed ID: 2145125 [No Abstract] [Full Text] [Related]
2. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone. Lauerma AI Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209 [TBL] [Abstract][Full Text] [Related]
3. [An unrecognized cause of allergic eczema of the face: a corticoid, tixocortol pivalate]. Foussereau J; Jelen G Presse Med; 1987 May; 16(17):832. PubMed ID: 2954110 [No Abstract] [Full Text] [Related]
4. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations. Shaw DW; Maibach HI Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037 [TBL] [Abstract][Full Text] [Related]
5. Hydrocortisone sensitivity. An investigation into the nature of the allergen. Wilkinson SM; English JS Contact Dermatitis; 1991 Sep; 25(3):178-81. PubMed ID: 1838313 [TBL] [Abstract][Full Text] [Related]
6. Reactivity of tixocortol pivalate-positive patients in intradermal and oral provocation tests. Räsänen L; Tuomi ML; Ylitalo L Br J Dermatol; 1996 Dec; 135(6):931-4. PubMed ID: 8977714 [TBL] [Abstract][Full Text] [Related]
11. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances. Isaksson M; Bruze M; Goossens A; Lepoittevin JP Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831 [TBL] [Abstract][Full Text] [Related]
12. Short induction phase of contact allergy to tixocortol pivalate in a nasal spray. Bircher AJ Contact Dermatitis; 1990 Apr; 22(4):237-8. PubMed ID: 2140756 [No Abstract] [Full Text] [Related]
13. Contact hypersensitivity to tixocortol pivalate. Lutz ME; el-Azhary RA; Gibson LE; Fransway AF J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812 [TBL] [Abstract][Full Text] [Related]
14. A survey of the results of patch tests with tixocortol pivalate. Dooms-Goossens A; Andersen KE; Burrows D; Camarasa JG; Ducombs G; Frosch PJ; Lachapelle JM; Lahti A; Menné T; Rycroft RJ Contact Dermatitis; 1989 Feb; 20(2):158. PubMed ID: 2706969 [No Abstract] [Full Text] [Related]
15. Contact allergy to corticosteroids: a frequently missed diagnosis? Dooms-Goossens AE; Degreef HJ; Mariën KJ; Coopman SA J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):538-43. PubMed ID: 2528573 [TBL] [Abstract][Full Text] [Related]
16. Patch testing to detect corticosteroid allergy: is it adequate? Seukeran DC; Wilkinson SM; Beck MH Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260 [TBL] [Abstract][Full Text] [Related]